Glenview Capital Management’s Labcorp LH Stock Holding History
Bought
Maintained
Sold
Other funds holding LH
Glenview Capital Management's LH Position: Q2 2023 in Review
Glenview Capital Management sold out of Labcorp (LH) in Q2 2023, closing a stake of 58,668 shares — an estimated $11.6M sold.
Glenview Capital Management first reported a position in LH in Q1 2014 and held it in 20 quarters. The position peaked at $711M in Q2 2016. 932 funds tracked by Wall St. Rank hold LH as of Q2 2023.
- Glenview Capital Management reported no remaining Labcorp position as of Q2 2023 after selling out during the quarter.
- Glenview Capital Management sold 58,668 Labcorp shares in Q2 2023, an estimated $11.6M.
- Glenview Capital Management first reported a position in Labcorp in Q1 2014 and held it in 20 quarters.
- Glenview Capital Management's Labcorp position peaked at $711M in Q2 2016.
- 932 funds tracked by Wall St. Rank held Labcorp as of Q2 2023.
Based on Glenview Capital Management's 13F filing for Q2 2023, filed 14 Aug 2023.